"U.S. approves sales of inhaled type of insulin"
Source: CBC.CA
Published: 27 Jan 2022
Category: Pharmaceutical
Rating:
(2½ stars)
what they said (Hover the mouse cursor over underlined words for more info)
Adult Americans with diabetes will soon be able to take an inhaled version of insulin to help manage their blood sugar levels.
The U.S. Food and Drug Administration approved the inhaled insulin, marketed as Exubera, on Friday.
The original article can be found at: http://www.cbc.ca/story/science/national/2006/01/27/insulin-inhale060127.html
The original article can found in the Media Doctor archives.
Criteria |
Rating |
Availability of Treatment |
Satisfactory (?) |
Novelty of Treatment |
Satisfactory (?) |
Disease Mongering |
Satisfactory (?) |
Treatment Options |
Not Satisfactory (?) |
Costs of Treatment |
Not Applicable |
Evidence |
Not Satisfactory (?) |
Quantification of Benefits of Treatment |
Not Satisfactory (?) |
Harms of Treatment |
Satisfactory (?) |
Sources of Information |
Not Satisfactory (?) |
Relies on Press Release |
Not Applicable |
Quantification of Harms of Treatment |
Not Satisfactory (?) |
what we said (Hover the mouse cursor over underlined words for more info)
This article, while it informs people about the potential of an inhaled form of insulin, does not mention or discuss any evidence of benefit or advantage over injectable insulin.
Although, in theory patients may prefer to inhale insulin, whether or not they choose this form of treatment will likely depend on cost, convenience and tolerability issues. There is a brief mention of some potential adverse effects of this agent.
It is hard to see how a story on this treatment (which has been approved in the US and Europe) benefits Canadians when the treatment is neither approved nor available in Canada and we have no information on cost or comparative safety of the treatment.
public forum
There are currently no comments on this article.
|